
Glimicost M 1mg/500mg Tablet
Marketer
Lamicon Pharma Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glimicost M 1mg/500mg Tablet
DiaBetaComb 1mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose. DiaBetaComb should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.
Primary Ingredients of Glimicost M 1mg/500mg Tablet
The provided text is "undefined," therefore, no rephrasing is possible.
Uses of Glimicost M 1mg/500mg Tablet
Managing type 2 diabetes
Major Benefits of Glimicost M 1mg/500mg Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimicost M 1mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.
Common Side effects of Glimicost M 1mg/500mg Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimicost M 1mg/500mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Glimicost M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
How Glimicost M 1mg/500mg Tablet works:
Glimicost M tablets (1mg/500mg) combine glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimicost M 1mg/500mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Glimicost M 1mg/500mg tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingUNSAFE
The drug Glimicost M 1mg/500mg tablets is contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimicost M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimicost M 1mg/500mg tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.
LiverCAUTION
For individuals with liver impairment, Glimicost M 1mg/500mg tablets require careful administration. Dosage modification may be necessary. Physician consultation is advised. A low initial dose of Glimicost M 1mg/500mg tablets is typically prescribed for patients exhibiting mild to moderate liver disease; however, its use is contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Glimicost M 1mg/500mg Tablet :
Should you forget to take your Glimicost M 1mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimicost M 1mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
